Correlation Between Orexo AB and Sdiptech
Specify exactly 2 symbols:
By analyzing existing cross correlation between Orexo AB and Sdiptech AB, you can compare the effects of market volatilities on Orexo AB and Sdiptech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orexo AB with a short position of Sdiptech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orexo AB and Sdiptech.
Diversification Opportunities for Orexo AB and Sdiptech
Very good diversification
The 3 months correlation between Orexo and Sdiptech is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Orexo AB and Sdiptech AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sdiptech AB and Orexo AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orexo AB are associated (or correlated) with Sdiptech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sdiptech AB has no effect on the direction of Orexo AB i.e., Orexo AB and Sdiptech go up and down completely randomly.
Pair Corralation between Orexo AB and Sdiptech
Assuming the 90 days trading horizon Orexo AB is expected to generate 4.19 times more return on investment than Sdiptech. However, Orexo AB is 4.19 times more volatile than Sdiptech AB. It trades about 0.01 of its potential returns per unit of risk. Sdiptech AB is currently generating about -0.03 per unit of risk. If you would invest 2,530 in Orexo AB on September 12, 2025 and sell it today you would lose (100.00) from holding Orexo AB or give up 3.95% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Orexo AB vs. Sdiptech AB
Performance |
| Timeline |
| Orexo AB |
| Sdiptech AB |
Orexo AB and Sdiptech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Orexo AB and Sdiptech
The main advantage of trading using opposite Orexo AB and Sdiptech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orexo AB position performs unexpectedly, Sdiptech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sdiptech will offset losses from the drop in Sdiptech's long position.| Orexo AB vs. XSpray Pharma AB | Orexo AB vs. Cantargia AB | Orexo AB vs. Senzime AB | Orexo AB vs. Sedana Medical AB |
| Sdiptech vs. MilDef Group AB | Sdiptech vs. Fagerhult AB | Sdiptech vs. Instalco Intressenter AB | Sdiptech vs. Inwido AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |